133 related articles for article (PubMed ID: 7853333)
1. Self-assembly of a quinobenzoxazine-Mg2+ complex on DNA: a new paradigm for the structure of a drug-DNA complex and implications for the structure of the quinolone bacterial gyrase-DNA complex.
Fan JY; Sun D; Yu H; Kerwin SM; Hurley LH
J Med Chem; 1995 Feb; 38(3):408-24. PubMed ID: 7853333
[TBL] [Abstract][Full Text] [Related]
2. Structural insight into a quinolone-topoisomerase II-DNA complex. Further evidence for a 2:2 quinobenzoxazine-mg2+ self-assembly model formed in the presence of topoisomerase ii.
Kwok Y; Zeng Q; Hurley LH
J Biol Chem; 1999 Jun; 274(24):17226-35. PubMed ID: 10358081
[TBL] [Abstract][Full Text] [Related]
3. Efficient, Mg(2+)-dependent photochemical DNA cleavage by the antitumor quinobenzoxazine (S)-A-62176.
Yu H; Kwok Y; Hurley LH; Kerwin SM
Biochemistry; 2000 Aug; 39(33):10236-46. PubMed ID: 10956013
[TBL] [Abstract][Full Text] [Related]
4. The quinobenzoxazines: relationship between DNA binding and biological activity.
Kwok Y; Sun D; Clement JJ; Hurley LH
Anticancer Drug Des; 1999 Oct; 14(5):443-50. PubMed ID: 10766299
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and evaluation of psorospermin/quinobenzoxazine hybrids as structurally novel antitumor agents.
Kim MY; Na Y; Vankayalapati H; Gleason-Guzman M; Hurley LH
J Med Chem; 2003 Jul; 46(14):2958-72. PubMed ID: 12825936
[TBL] [Abstract][Full Text] [Related]
6. Interactions between fluoroquinolones, Mg2+, DNA and DNA gyrase, studied by phase partitioning in an aqueous two-phase system and by affinity chromatography.
Khac SB; Moreau NJ
J Chromatogr A; 1994 May; 668(1):241-7. PubMed ID: 7516247
[TBL] [Abstract][Full Text] [Related]
7. Quinolone binding to DNA is mediated by magnesium ions.
Palù G; Valisena S; Ciarrocchi G; Gatto B; Palumbo M
Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9671-5. PubMed ID: 1409681
[TBL] [Abstract][Full Text] [Related]
8. Mg(2+)-mediated binding of 6-substituted quinolones to DNA: relevance to biological activity.
Sissi C; Andreolli M; Cecchetti V; Fravolini A; Gatto B; Palumbo M
Bioorg Med Chem; 1998 Sep; 6(9):1555-61. PubMed ID: 9801827
[TBL] [Abstract][Full Text] [Related]
9. A comparison of active site binding of 4-quinolones and novel flavone gyrase inhibitors to DNA gyrase.
Hilliard JJ; Krause HM; Bernstein JI; Fernandez JA; Nguyen V; Ohemeng KA; Barrett JF
Adv Exp Med Biol; 1995; 390():59-69. PubMed ID: 8718602
[TBL] [Abstract][Full Text] [Related]
10. Quinolones share a common interaction domain on topoisomerase II with other DNA cleavage-enhancing antineoplastic drugs.
Elsea SH; Westergaard M; Burden DA; Lomenick JP; Osheroff N
Biochemistry; 1997 Mar; 36(10):2919-24. PubMed ID: 9062121
[TBL] [Abstract][Full Text] [Related]
11. Design of new topoisomerase II inhibitors based upon a quinobenzoxazine self-assembly model.
Zeng Q; Kwok Y; Kerwin SM; Mangold G; Hurley LH
J Med Chem; 1998 Oct; 41(22):4273-8. PubMed ID: 9784102
[TBL] [Abstract][Full Text] [Related]
12. Quinolone mode of action--new aspects.
Hooper DC
Drugs; 1993; 45 Suppl 3():8-14. PubMed ID: 7689456
[TBL] [Abstract][Full Text] [Related]
13. Mode of action of the quinolone antimicrobial agents: review of recent information.
Hooper DC; Wolfson JS
Rev Infect Dis; 1989; 11 Suppl 5():S902-11. PubMed ID: 2549608
[TBL] [Abstract][Full Text] [Related]
14. DNA gyrase-mediated wrapping of the DNA strand is required for the replication fork arrest by the DNA gyrase-quinolone-DNA ternary complex.
Hiasa H; Shea ME
J Biol Chem; 2000 Nov; 275(44):34780-6. PubMed ID: 11053451
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antitumour activities of quinolone antineoplastic agents.
Chu DT; Hallas R; Clement JJ; Alder J; McDonald E; Plattner JJ
Drugs Exp Clin Res; 1992; 18(7):275-82. PubMed ID: 1338309
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of quinolone inhibition of DNA gyrase. Appearance of unique norfloxacin binding sites in enzyme-DNA complexes.
Shen LL; Kohlbrenner WE; Weigl D; Baranowski J
J Biol Chem; 1989 Feb; 264(5):2973-8. PubMed ID: 2536729
[TBL] [Abstract][Full Text] [Related]
17. The complex of DNA gyrase and quinolone drugs with DNA forms a barrier to transcription by RNA polymerase.
Willmott CJ; Critchlow SE; Eperon IC; Maxwell A
J Mol Biol; 1994 Sep; 242(4):351-63. PubMed ID: 7932695
[TBL] [Abstract][Full Text] [Related]
18. The DNA gyrase-quinolone complex. ATP hydrolysis and the mechanism of DNA cleavage.
Kampranis SC; Maxwell A
J Biol Chem; 1998 Aug; 273(35):22615-26. PubMed ID: 9712890
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug--DNA binding model.
Shen LL; Mitscher LA; Sharma PN; O'Donnell TJ; Chu DW; Cooper CS; Rosen T; Pernet AG
Biochemistry; 1989 May; 28(9):3886-94. PubMed ID: 2546585
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of quinolone action. A drug-induced structural perturbation of the DNA precedes strand cleavage by topoisomerase IV.
Marians KJ; Hiasa H
J Biol Chem; 1997 Apr; 272(14):9401-9. PubMed ID: 9083078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
